Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest announcement is out from DBV Technologies SA – American ( (DBVT) ).
DBV Technologies Inc., a subsidiary of DBV Technologies S.A., has amended employment agreements for its Chief Medical Officer, Pharis Mohideen, and Chief Financial Officer, Virginie Boucinha, to include enhanced severance benefits in the event of a Change in Control. These amendments, approved by the Board of Directors, provide specific financial compensations and benefits to the executives if their employment is terminated under certain conditions following a Change in Control, reflecting the company’s commitment to retaining key leadership during potential organizational changes.
More about DBV Technologies SA – American
YTD Price Performance: -66.32%
Average Trading Volume: 249,591
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $64.5M
For detailed information about DBVT stock, go to TipRanks’ Stock Analysis page.
